» Articles » PMID: 19171647

Expression of Matrix Metalloproteinases During Experimental Candida Albicans Keratitis

Overview
Specialty Ophthalmology
Date 2009 Jan 28
PMID 19171647
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study was designed to investigate the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) during the inception and progression of experimental keratomycosis.

Methods: Scarified corneas of adult BALB/c mice were topically inoculated with Candida albicans strain SC5314 and monitored for disease severity. Infected and mock-infected corneas were compared at 1 day post inoculation (p.i.) with a murine gene microarray. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) determined MMP and TIMP levels at 1, 3, and 7 days p.i. for infected, mock-infected, and normal corneas. Immunostaining localized target proteins at 1 day p.i.

Results: Eyes inoculated with C. albicans developed corneal infection with a mean clinical score of 8.2+/-0.8 at 1 day p.i. Compared to controls at 1 day p.i., MMP-8, -9, -10, -12, -13, -19, and TIMP-1 were significantly upregulated from fivefold to 375-fold by microarray and from threefold to 78-fold by real-time RT-PCR. Upregulated MMPs and TIMP-1 in the corneal epithelium and stroma of infected eyes correlated with the influx of acute inflammatory cells. Neither MMP-8 nor -13 expression was affected by mechanical trauma, but both increased >100-fold during the week after the onset of fungal keratitis. TIMP-1 expression rose from 21-fold more than controls at 1 day to 46-fold at 7 days p.i. by RT-PCR.

Conclusions: Transcriptional and translational levels of MMP-8, -9, -13, and TIMP-1 increase during the early stages of C. albicans keratitis, confirming findings for MMP-9 and TIMP-1 in other infectious keratitis models and suggesting roles for MMP-8 and -13.

Citing Articles

Exploring the role of oral bacteria in oral cancer: a narrative review.

Mivehchi H, Eskandari-Yaghbastlo A, Pour Bahrami P, Elhami A, Faghihinia F, Nejati S Discov Oncol. 2025; 16(1):242.

PMID: 40009328 PMC: 11865422. DOI: 10.1007/s12672-025-01998-2.


Matrix Metalloproteinases and the Pathogenesis of Recurrent Corneal Erosions and Epithelial Basement Membrane Dystrophy.

Jadczyk-Sorek K, Garczorz W, Bubala-Stachowicz B, Francuz T, Mrukwa-Kominek E Biology (Basel). 2023; 12(9).

PMID: 37759662 PMC: 10525265. DOI: 10.3390/biology12091263.


How Modifications of Corneal Cross-Linking Protocols Influence Corneal Resistance to Enzymatic Digestion and Treatment Depth.

Kowalska M, Mischi E, Stoma S, Norrelykke S, Hartnack S, Pot S Transl Vis Sci Technol. 2023; 12(5):18.

PMID: 37191620 PMC: 10198285. DOI: 10.1167/tvst.12.5.18.


Amino Acid Sensing and Assimilation by the Fungal Pathogen in the Human Host.

Silao F, Ljungdahl P Pathogens. 2022; 11(1).

PMID: 35055954 PMC: 8781990. DOI: 10.3390/pathogens11010005.


Candida albicans and candidalysin in inflammatory disorders and cancer.

Ho J, Camilli G, Griffiths J, Richardson J, Kichik N, Naglik J Immunology. 2020; 162(1):11-16.

PMID: 32880925 PMC: 7730014. DOI: 10.1111/imm.13255.


References
1.
Ma J, Dohlman C . Mechanisms of corneal ulceration. Ophthalmol Clin North Am. 2002; 15(1):27-33. DOI: 10.1016/s0896-1549(01)00017-7. View

2.
Xue M, Wakefield D, Willcox M, Lloyd A, Di Girolamo N, Cole N . Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci. 2003; 44(5):2020-5. DOI: 10.1167/iovs.02-0565. View

3.
Sivak J, Fini M . MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002; 21(1):1-14. DOI: 10.1016/s1350-9462(01)00015-5. View

4.
Ikema K, Matsumoto K, Inomata Y, Komohara Y, Miyajima S, Takeya M . Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis. Exp Eye Res. 2006; 83(6):1396-404. DOI: 10.1016/j.exer.2006.07.019. View

5.
Lee M, Yoon B, Osiewicz K, Preston M, Bundy B, van Heeckeren A . Tissue inhibitor of metalloproteinase 1 regulates resistance to infection. Infect Immun. 2004; 73(1):661-5. PMC: 538985. DOI: 10.1128/IAI.73.1.661-665.2005. View